📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. (2021)

First Author: Barrett JR

Attributed to: The Future Vaccine Manufacturing Research Hub (Vax-Hub) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-020-01179-4

PubMed Identifier: 33335322

Publication URI: http://europepmc.org/abstract/MED/33335322

Type: Journal Article/Review

Volume: 27

Parent Publication: Nature medicine

Issue: 2

ISSN: 1078-8956